Literature DB >> 1974283

Neuroleptic malignant syndrome.

A V Srinivasan1, M Murugappan, S G Krishnamurthy, Z A Sayeed.   

Abstract

Five patients with neuroleptic malignant syndrome (NMS) are described. The syndrome developed earlier and took longer to resolve in patients with schizophrenic disorders. Deterioration in the level of consciousness presented earlier than rigidity and fever in all five patients and was thus considered a major criterion. A significant proportion of the patients showed abnormalities of gaze. In four of the five patients spontaneous recovery occurred without the need for specific drugs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1974283      PMCID: PMC1014213          DOI: 10.1136/jnnp.53.6.514

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  16 in total

Review 1.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

2.  Dopamine receptors in the central thermoregulatory pathways of the rat.

Authors:  B Cox; R Kerwin; T F Lee
Journal:  J Physiol       Date:  1978-09       Impact factor: 5.182

Review 3.  Drugs and body temperature.

Authors:  P Lomax
Journal:  Int Rev Neurobiol       Date:  1970       Impact factor: 3.230

4.  Total gaze paresis in amitriptyline overdose.

Authors:  E K Miadinich; T J Carlow
Journal:  Neurology       Date:  1977-07       Impact factor: 9.910

5.  Neuroleptic-induced extrapyramidal symptoms with fever. Heterogeneity of the 'neuroleptic malignant syndrome'.

Authors:  D F Levinson; G M Simpson
Journal:  Arch Gen Psychiatry       Date:  1986-09

6.  Ataxia and nystagmus induced by injection of local anesthetics in the Neck.

Authors:  P T de Jong; J M de Jong; B Cohen; L B Jongkees
Journal:  Ann Neurol       Date:  1977-03       Impact factor: 10.422

7.  Reduction in brain dopamine following experimental cerebral ischaemia.

Authors:  N T Zervas; H Hori; M Negora; R J Wurtman; F Larin; M H Lavyne
Journal:  Nature       Date:  1974-02-01       Impact factor: 49.962

8.  Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade?

Authors:  V W Henderson; G F Wooten
Journal:  Neurology       Date:  1981-02       Impact factor: 9.910

9.  Neuroleptic malignant syndrome.

Authors:  H H Morris; W F McCormick; J A Reinarz
Journal:  Arch Neurol       Date:  1980-07

10.  The neuroleptic malignant syndrome.

Authors:  S N Caroff
Journal:  J Clin Psychiatry       Date:  1980-03       Impact factor: 4.384

View more
  2 in total

1.  Misconceptions and inappropriate use of terms in hyperthermic syndromes.

Authors:  B J Van Hilten; R A Roos
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-10       Impact factor: 10.154

2.  Neuroleptic malignant syndrome in an AIDS patient: clinical and pathological findings.

Authors:  A S Gabellini; A Pezzoli; P De Massis; G Casadei; A Grillo; T Sacquegna
Journal:  Ital J Neurol Sci       Date:  1994-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.